SPECIAL NOTICE
A -- - NTP mix, -SP6 RNA Polymerase + RNase inhibitor, -5x Transcription Buffer LM, -WEORI 7240G,-WEPRO 7240H, -40x SUBAMIX SGC (4x12.5ml)
- Notice Date
- 5/5/2017
- Notice Type
- Special Notice
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of the Navy, Bureau of Medicine and Surgery, U.S. Naval Medical Research Unit - 6 Peru, Unit 3230 Box 343, American Embassy, DPO AA 34031-0343, Lima, Non-U.S., 34031-0343, Peru
- ZIP Code
- 00000
- Solicitation Number
- Namru-6Plasmadium
- Archive Date
- 6/6/2017
- Point of Contact
- Ana C. Salinas, Phone: 5116144141, Javier B. Gil, Phone: 5116144152
- E-Mail Address
-
ana.c.salinas.fn@mail.mil, javier.b.gil.fn@mail.mil
(ana.c.salinas.fn@mail.mil, javier.b.gil.fn@mail.mil)
- Small Business Set-Aside
- Partial Small Business
- Description
- The U.S. Naval Medical Research Unit No. 6 (NAMRU-6) in Peru, in partnership with the Malaria Vaccine Program at the Naval Medical Research Center (NMRC), Silver Spring, MD is evaluating as Minimum requirement include a eukaryotic expression system capable of producing proteins with correct folding, post-translational modification and high yields (milligram amounts) with little endotoxin contamination. Additionally, we require an expression system which is highly efficient to express Plasmodium genes which are rich in adenine and thymidine base pairs. The proteins produced should be able to be used in animal models for vaccine evaluation purposes. Background: wheat germ system allows a higher quality of protein synthesis in a wider temperature range. Carrying out expressions at a different temperature range allows the production of a wider protein spectrum. On the other hand, this wheat germ expression system has no codon preference so it is highly efficient for expressing Plasmodium genes which codon usage is unique. Furthermore, for many proteins, the system is more cost-effective than insect or mammalian cell expression systems, as it requires no tissue culture facilities. General Requirements : Item: - NTP mix - SP6 RNA Polymerase + RNase inhibitor - 5x Transcription Buffer LM - WEORI 7240G - WEPRO 7240H - 40x SUBAMIX SGC (4x12.5ml) Place of Performance: NAVAL MEDICAL RESEARCH UNIT 6 - NAMRU-6 Period of Performance: After items be delivered at the above mention place of performance If capable sources are not identified through this notice, then NAMRU 6 intends to award a sole source contract under the authority of FAR 13.106-1(b)(i) to CELL FREE SCIENCES Co. Ltd. Our institution has used this source for these items the past 2014 using our institutional purchasing system at NAMRU-6. The purchase order number was N44852-14-P-0246 and the order was made effective on May 19, 2014. This pre-solicitation is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract. Capability statements are due by 12:00 AM Local Time, May 22, 2017. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: ana.c.salinas.fn@mail.mil. Please use subject line "Namru-6 Plasmadium
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/f9499cc4250dcccd2e5e109f022aa940)
- Place of Performance
- Address: NAVAL MEDICAL RESEARCH UNIT 6 - NAMRU6, Av. Venezuela cda. 36 s/n, Bellavista, Callao 1, Perú, Lima, Non-U.S., Callao 1, Peru
- Record
- SN04497527-W 20170507/170505234058-f9499cc4250dcccd2e5e109f022aa940 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |